ASCITES HEPATIC
Clinical trials for ASCITES HEPATIC explained in plain language.
Never miss a new study
Get alerted when new ASCITES HEPATIC trials appear
Sign up with your email to follow new studies for ASCITES HEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shunt procedure could extend life for liver patients
Disease control Recruiting nowThis study compares early placement of a TIPS (a small tube that reroutes blood flow in the liver) against standard treatments like diuretics and fluid drainage in 134 patients with liver cirrhosis and ascites (fluid buildup). The goal is to see if TIPS improves survival and redu…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: University Hospital Freiburg • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Smaller stent, bigger hope: new TIPS technique aims to prevent brain fog
Disease control Recruiting nowThis study tests a technique called 'underdilated stent' during a liver shunt procedure (TIPS) for people with cirrhosis. The goal is to see if using a smaller balloon to place the stent can lower the risk of hepatic encephalopathy (brain confusion) after the procedure, while sti…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New liver stent aims to tame deadly cirrhosis complications
Disease control Recruiting nowThis study tests a special stent called LIVERTY TIPS, placed in the liver to create a new pathway for blood flow in people with cirrhosis and high blood pressure in the liver. The goal is to see if it can keep the new channel open and reduce problems like bleeding or fluid buildu…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New injection aims to tame liver Scarring—First human trial underway
Disease control Recruiting nowThis early-stage trial is testing a new drug called PHIN-214 (a modified version of terlipressin) in 74 adults with mild-to-moderate liver cirrhosis. The study has two parts: a single dose and then daily injections for 28 days. The main goals are to check safety, find the best do…
Matched conditions: ASCITES HEPATIC
Phase: PHASE1 • Sponsor: PharmaIN • Aim: Disease control
Last updated Jun 26, 2026 13:41 UTC
-
New study aims to understand how ascites affects daily life and muscle health
Knowledge-focused Recruiting nowThis study follows 70 adults with refractory ascites (fluid buildup in the belly that doesn't respond to standard treatment) caused by liver disease or cancer. Researchers will use surveys to measure quality of life and CT scans to track muscle loss (sarcopenia) over time. The go…
Matched conditions: ASCITES HEPATIC
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC